A new study showed that semaglutide may help with alcohol use disorder Steve Christo - Corbis/Corbis via Getty; Getty A new study (the first clinical trial of its kind) has shown that the GLP-1 ...

A triple-sized weekly dose of Ozempic works better to help people with obesity shed excess pounds without significant side effects, new clinical trial results show. Obese folks lost more weight taking ...

Only 15% of GLP-1 users persisted after two years, with 29% still on medication after one year. A real-world study showed patients lost an average of 3.7% body weight after one year on GLP-1s. 9 Out ...

Scientists have failed to show that weight-loss wonder drug semaglutide slows the progress of Alzheimer's disease (AD), as two-year clinical trials end in disappointment for patients, medical ...

(Left:) Stock image of Ozempic; (Right:) Stock image of someone taking a bottle of alcohol off a shelf. A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide ...